Andrew F. Trofa

1.9k total citations
24 papers, 1.3k citations indexed

About

Andrew F. Trofa is a scholar working on Epidemiology, Endocrinology and Hepatology. According to data from OpenAlex, Andrew F. Trofa has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Endocrinology and 8 papers in Hepatology. Recurrent topics in Andrew F. Trofa's work include Hepatitis Viruses Studies and Epidemiology (7 papers), Hepatitis B Virus Studies (7 papers) and Vibrio bacteria research studies (6 papers). Andrew F. Trofa is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (7 papers), Hepatitis B Virus Studies (7 papers) and Vibrio bacteria research studies (6 papers). Andrew F. Trofa collaborates with scholars based in United States, Netherlands and Australia. Andrew F. Trofa's co-authors include Jerald Sadoff, David N. Taylor, David T. Beattie, Trinka S. Coster, Kevin Killeen, Julie Kenner, John J. Mekalanos, Mira Baron, Francis Dessy and Gary Dubin and has published in prestigious journals such as The Lancet, JAMA and PEDIATRICS.

In The Last Decade

Andrew F. Trofa

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew F. Trofa United States	14	468	409	359	303	225	24	1.3k
Thomas C. Darton United Kingdom	21	345 0.7×	258 0.6×	687 1.9×	251 0.8×	161 0.7×	77	1.3k
Lars Rombo Sweden	23	185 0.4×	615 1.5×	426 1.2×	189 0.6×	455 2.0×	47	1.4k
M. Cadoz France	22	462 1.0×	956 2.3×	824 2.3×	334 1.1×	172 0.8×	45	2.2k
Marianne Jertborn Sweden	27	1.2k 2.5×	409 1.0×	868 2.4×	606 2.0×	145 0.6×	50	2.1k
R. Slepon Israel	17	476 1.0×	223 0.5×	651 1.8×	127 0.4×	109 0.5×	38	1.1k
Rina Meza Peru	21	546 1.2×	144 0.4×	455 1.3×	170 0.6×	98 0.4×	40	1.3k
Kawsar R. Talaat United States	22	204 0.4×	599 1.5×	732 2.0×	250 0.8×	373 1.7×	53	1.4k
Dolores A. Bryla United States	26	803 1.7×	464 1.1×	1.1k 3.0×	299 1.0×	111 0.5×	39	2.3k
R Cisterna Spain	20	160 0.3×	603 1.5×	469 1.3×	112 0.4×	82 0.4×	140	1.4k
S J Cryz Switzerland	19	249 0.5×	301 0.7×	277 0.8×	237 0.8×	114 0.5×	26	904

Countries citing papers authored by Andrew F. Trofa

Since Specialization

Citations

This map shows the geographic impact of Andrew F. Trofa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew F. Trofa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew F. Trofa more than expected).

Fields of papers citing papers by Andrew F. Trofa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew F. Trofa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew F. Trofa. The network helps show where Andrew F. Trofa may publish in the future.

Co-authorship network of co-authors of Andrew F. Trofa

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew F. Trofa. A scholar is included among the top collaborators of Andrew F. Trofa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew F. Trofa. Andrew F. Trofa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giunta, Riccardo E., et al.. (2024). Treatment of progressive myopia with 0.01% Atropine in children and adolescents: an Italian 4-year follow-up study.. PubMed. 175(5). 265–270. 1 indexed citations

Ghaswalla, Parinaz, et al.. (2019). The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015. Preventive Medicine Reports. 14. 100833–100833. 2 indexed citations

Meeren, Olivier Van Der, James T. Peterson, Marc Dionne, et al.. (2016). Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. Human Vaccines & Immunotherapeutics. 12(8). 2197–2203. 24 indexed citations

Trofa, Andrew F., Nicola P. Klein, Ian M. Paul, et al.. (2011). Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Diphtheria-tetanus-acellular Pertussis and Haemophilus influenzae Type B Vaccines in Children 15 Months of Age. The Pediatric Infectious Disease Journal. 30(9). e164–e169. 2 indexed citations

Michaels, Marian G., et al.. (2011). Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Measles-mumps-rubella and Varicella Vaccines in Children Less Than 2 Years of Age. The Pediatric Infectious Disease Journal. 30(10). e179–e185. 8 indexed citations

Einstein, Mark H., Mira Baron, Myron J. Levin, et al.. (2009). Comparison of the immunogenicity and safety ofCervarix™ andGardasil^®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Human Vaccines. 5(10). 705–719. 295 indexed citations

Trofa, Andrew F., Michael Levin, Colin D. Marchant, James Hedrick, & Mark M. Blatter. (2008). Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly With a Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age. The Pediatric Infectious Disease Journal. 27(7). 658–660. 5 indexed citations

Connor, Bradley A., Mark M. Blatter, Jiřı́ Beran, Bin Zou, & Andrew F. Trofa. (2007). Rapid and Sustained Immune Response Against Hepatitis A and B Achieved With Combined Vaccine Using an Accelerated Administration Schedule. Journal of Travel Medicine. 14(1). 9–15. 22 indexed citations

Trofa, Andrew F., et al.. (1999). Dr. Kiyoshi Shiga: Discoverer of the Dysentery Bacillus. Clinical Infectious Diseases. 29(5). 1303–1306. 65 indexed citations

10.

Blacksin, Marcia F., Sheldon S. Lin, & Andrew F. Trofa. (1999). Filariasis of the Ankle: Magnetic Resonance Imaging. Foot & Ankle International. 20(11). 738–740. 4 indexed citations

11.

Drabick, Joseph J., et al.. (1997). A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine. Vaccine. 15(10). 1144–1148. 4 indexed citations

12.

Heppner, D. Gray, Daniel M. Gordon, Mitchell Gross, et al.. (1996). Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes. The Journal of Infectious Diseases. 174(2). 361–366. 75 indexed citations

13.

Killeen, Kevin, David T. Beattie, David R. Spriggs, et al.. (1995). Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype. The Lancet. 345(8955). 949–952. 110 indexed citations

14.

Kenner, Julie, Trinka S. Coster, David N. Taylor, et al.. (1995). Peru-15, an Improved Live Attenuated Oral Vaccine Candidate for Vibrio cholerae O1. The Journal of Infectious Diseases. 172(4). 1126–1129. 103 indexed citations

15.

Sharp, Trueman W., Kenneth C. Hyams, Douglas M. Watts, et al.. (1995). Epidemiology of Norwalk virus during an outbreak of acute gastroenteritis aboard a US aircraft carrier. Journal of Medical Virology. 45(1). 61–67. 46 indexed citations

16.

Mekalanos, John J., Matthew K. Waldor, Claudette L. Gardel, et al.. (1995). Live cholera vaccines: perspectives on their construction and safety. 93(4). 255–262. 16 indexed citations

17.

Ramsey, Kyle H., et al.. (1994). Inflammatory Cytokine Response to Experimental Human Infection with Neisseria gonorrhoeae. Annals of the New York Academy of Sciences. 730(1). 322–325. 10 indexed citations

18.

Taylor, David N., Kevin Killeen, Julie Kenner, et al.. (1994). Development Of A Live, Oral, Attenuated Vaccine Against El Tor Cholera. The Journal of Infectious Diseases. 170(6). 1518–1523. 88 indexed citations

19.

Sánchez, José L., Andrew F. Trofa, David N. Taylor, et al.. (1993). Safety and Immunogenicity of the Oral, Whole Cell/Recombinant B Subunit Cholera Vaccine in North American Volunteers. The Journal of Infectious Diseases. 167(6). 1446–1449. 45 indexed citations

20.

Hoge, Charles W., Andrew F. Trofa, S Migasena, et al.. (1992). Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand. The Journal of Infectious Diseases. 165(6). 1042–1048. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact